Last reviewed · How we verify
Phenylephrine-P
At a glance
| Generic name | Phenylephrine-P |
|---|---|
| Also known as | vasopressor |
| Sponsor | Dalian Municipal Central Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults (PHASE1)
- COMPARISON BETWEEN EFFICACY OF NOREPINEPHRINE AND PHENYLEPHRINE BOLUSES for PREVENTION OF SPINAL ANAESTHESIA INDUCED HYPOTENSION IN OBSTETRICAL PATIENTS UNDERGOING EMERGENCY CESAREAN SECTION-A Double Blind Randomized Controlled Trial (NA)
- A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia (PHASE4)
- Comparative Analytical Study of Intravenous Bolus Dose of Mephentermine and Phenylephrine for Hemodynamic Stability During Elective Cesarean Section Under Spinal Anesthesia at KIST Medical College and Teaching Hospital (PHASE3)
- A Study Investigating Whether Low Dose Eyedrops for Pupil Dilation is as Effective and Safe as Standard Dose Eyedrops in Examination for Retinopathy of Prematurity. (EARLY_PHASE1)
- Effect of Estetrol Monohydrate (E4) on QTc Interval (PHASE1)
- Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects (EARLY_PHASE1)
- Effect of Three Weight-adjusted Vasopressors for Elective Cesarean Delivery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenylephrine-P CI brief — competitive landscape report
- Phenylephrine-P updates RSS · CI watch RSS
- Dalian Municipal Central Hospital portfolio CI